Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial (2009)

First Author: Kenemans P

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/S1470-2045(08)70341-3

Publication URI: http://dx.doi.org/10.1016/S1470-2045(08)70341-3

Type: Journal Article/Review

Parent Publication: The Lancet Oncology

Issue: 2